Skip to content
S8807Senate2023-2024 Session

Study Ibogaine for PTSD

Official title

“Directs the commissioner of health to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder”

Sponsor Jake AshbySD-43+1 co-sponsorAffects Health
Status
In Senate Committee
Health
Impact
4/10
Low
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill directs New York's health commissioner to study ibogaine as a treatment for PTSD, especially in veterans and first responders.

Why it matters

  1. Explores Alternative Treatments. By studying ibogaine, a psychedelic compound not currently approved for medical use in the U.S., New York could pave the way for new, potentially more effective PTSD therapies, especially for those who haven't responded to existing treatments.

  2. Focuses on High-Risk Groups. The bill centers attention on veterans and first responders, populations with elevated rates of PTSD and suicide, signaling a targeted effort to address mental health crises in those who have served the public.

  3. Evaluates Safety and Risks. The mandated study will not just look at potential benefits but will also scrutinize risks and appropriateness, helping ensure any policy or future use is grounded in evidence and prioritizes patient safety.

  4. Could Influence Broader Policy. The findings and recommendations from this report may inform not only state-level decisions but also contribute to national conversations on psychedelic research, mental health care innovation, and veteran services.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Study Ibogaine for PTSD

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Jake Ashby

Senator · Senate District 43

1 Co-sponsor

History

  1. Referred to health

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8807

IN SENATE

March 14, 2024

Introduced by Sen. ASHBY -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT in relation to to directing the commissioner of health to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. 1. The commissioner of health, in conjunction with the commissioner of mental health and the commissioner of veterans' services, is authorized and directed to conduct a study to research the use of ibogaine as a treatment for post-traumatic stress disorder and the increasing rate of diagnoses of post-traumatic stress disorder in veterans and first responders.

2. The study conducted pursuant to subdivision 1 of this section shall examine any possible benefits and risks, and the appropriateness and effectiveness of ibogaine as a treatment for post-traumatic stress disorder.

3. The commissioner of health shall submit a report on the findings of the study conducted pursuant to subdivision 1 of this section, and recommendations, to the governor, the speaker of the assembly, the temporary president of the senate, the minority leader of the senate, the minority leader of the assembly and all members of each house of the New York state legislature no later than one year following the effective date of this act.

§ 2. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD14849-01-4

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act in relation to to directing the commissioner of health to conduct a study on the use of ibogaine as a treatment for post-traumatic stress disorder

Purpose or general idea of bill

To study and provide recommendations on the use of ibogaine to treat post-traumatic stress disorder, especially among veterans and first responders.

Summary of provisions

Section 1 authorizes and directs the commissioner of health, in conjunc- tion with the commissioner of mental health and the commissioner of veterans' services to conduct a study to research the use of ibogaine to treat post-traumatic stress disorder, specifically among veterans and first responders.

Also requires a report of findings and recommendations be submitted to the governor, the speaker of the assembly, temporary president of the senate, the minority leader of the senate, the minority leader of the assembly and all members of both houses of the legislature, within 1 year of the effective date.

Section 2 sets the effective date.

Justification

Post-traumatic stress disorder is a mental health problem that can occur after a traumatic event like war, assault or disaster. Every case is different and there is no cure. Our veterans and first responders deserve to have all possible treatments studied and evaluated.

This bill seeks to study the possible benefits and risks, as well as the appropriateness and effectiveness, of ibogaine as a treatment for PTSD. This study would have a special focus on veterans and first responders.

Ibogaine is a naturally occurring psychoactive substance, hallucinogenic compound derived from the roots of a West African shrub. It has been used experimentally to treat heroin or cocaine addiction and for depression and PTSD.

The study would be conducted by the commissioner of health in conjunc- tion with the commissioner of mental health and the commissioner of veterans' services; and they would be required to report their findings and recommendations.

Prior legislative history

New bill

Fiscal implications

To be determined.

Effective date

This act shall take effect immediately

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.